Back to Search
Start Over
Antibacterial activity of sphingoid bases and fatty acids against Gram-positive and Gram-negative bacteria.
- Source :
-
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2012 Mar; Vol. 56 (3), pp. 1157-61. Date of Electronic Publication: 2011 Dec 12. - Publication Year :
- 2012
-
Abstract
- There is growing evidence that the role of lipids in innate immunity is more important than previously realized. How lipids interact with bacteria to achieve a level of protection, however, is still poorly understood. To begin to address the mechanisms of antibacterial activity, we determined MICs and minimum bactericidal concentrations (MBCs) of lipids common to the skin and oral cavity--the sphingoid bases D-sphingosine, phytosphingosine, and dihydrosphingosine and the fatty acids sapienic acid and lauric acid--against four Gram-negative bacteria and seven Gram-positive bacteria. Exact Kruskal-Wallis tests of these values showed differences among lipid treatments (P < 0.0001) for each bacterial species except Serratia marcescens and Pseudomonas aeruginosa. D-sphingosine (MBC range, 0.3 to 19.6 μg/ml), dihydrosphingosine (MBC range, 0.6 to 39.1 μg/ml), and phytosphingosine (MBC range, 3.3 to 62.5 μg/ml) were active against all bacteria except S. marcescens and P. aeruginosa (MBC > 500 μg/ml). Sapienic acid (MBC range, 31.3 to 375.0 μg/ml) was active against Streptococcus sanguinis, Streptococcus mitis, and Fusobacterium nucleatum but not active against Escherichia coli, Staphylococcus aureus, S. marcescens, P. aeruginosa, Corynebacterium bovis, Corynebacterium striatum, and Corynebacterium jeikeium (MBC > 500 μg/ml). Lauric acid (MBC range, 6.8 to 375.0 μg/ml) was active against all bacteria except E. coli, S. marcescens, and P. aeruginosa (MBC > 500 μg/ml). Complete killing was achieved as early as 0.5 h for some lipids but took as long as 24 h for others. Hence, sphingoid bases and fatty acids have different antibacterial activities and may have potential for prophylactic or therapeutic intervention in infection.
- Subjects :
- Anti-Bacterial Agents immunology
Gram-Negative Bacteria growth & development
Gram-Negative Bacterial Infections immunology
Gram-Negative Bacterial Infections prevention & control
Gram-Positive Bacteria growth & development
Gram-Positive Bacterial Infections immunology
Gram-Positive Bacterial Infections prevention & control
Humans
Lauric Acids immunology
Lauric Acids metabolism
Lauric Acids pharmacology
Microbial Sensitivity Tests
Mouth microbiology
Palmitic Acids immunology
Palmitic Acids metabolism
Palmitic Acids pharmacology
Skin microbiology
Species Specificity
Sphingosine analogs & derivatives
Sphingosine immunology
Sphingosine metabolism
Sphingosine pharmacology
Anti-Bacterial Agents pharmacology
Gram-Negative Bacteria drug effects
Gram-Positive Bacteria drug effects
Immunity, Innate
Mouth immunology
Skin immunology
Subjects
Details
- Language :
- English
- ISSN :
- 1098-6596
- Volume :
- 56
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Antimicrobial agents and chemotherapy
- Publication Type :
- Academic Journal
- Accession number :
- 22155833
- Full Text :
- https://doi.org/10.1128/AAC.05151-11